|
|
Volumn 32, Issue 19, 2014, Pages 2115-2116
|
|
Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy Trials
a b c d e f g h i j a j k l m i |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADMINISTRATIVE PERSONNEL;
CANCER CENTER;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL DECISION MAKING;
CLINICAL TRIAL (TOPIC);
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
FOLLOW UP;
HUMAN;
IMAGING;
LETTER;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
QUANTITATIVE IMAGING;
RADIOLOGY DEPARTMENT;
STUDY DESIGN;
TREATMENT RESPONSE;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DIAGNOSTIC IMAGING;
DISEASE PROGRESSION;
HUMANS;
INFLAMMATION;
NATIONAL CANCER INSTITUTE (U.S.);
NEOPLASMS;
PREDICTIVE VALUE OF TESTS;
RESEARCH SUPPORT AS TOPIC;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 84905828904
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2014.55.8866 Document Type: Letter |
|
Times cited : (15)
|
|
References (4)
|
